Nano Dimension Ltd. — FY2023 Form 20-F Summary
Reporting period: Fiscal year ended December 31, 2023. This is an annual report, not a standalone fourth-quarter filing; the supplied text does not provide a clear Q4-only financial result. Financial statements are prepared under IFRS as issued by the IASB, in U.S. dollars.
Business context
Nano Dimension develops and sells additive manufacturing systems, materials, software and services for electronics and precision mechanical manufacturing. Its portfolio includes DragonFly electronics printers, Fabrica micro-AM printers, Admaflex ceramic and metal printers, Essemtec electronics-assembly equipment, GIS ink-delivery systems, and DeepCube industrial AI. The company’s growth strategy emphasizes R&D, commercialization and acquisitions. In August 2023 it acquired Additive Flow intellectual property; it also held about 14.02% of Stratasys at year-end and had made an unaccepted proposal to acquire the remaining shares for $16.50 per share.
Financial performance
| Metric (USD millions, except per-share data) | 2023 | 2022 | Change / context |
|---|---|---|---|
| Revenue | 56.314 | 43.633 | Up 29%; growth attributed mainly to sales efforts, particularly in Western Europe and the U.S. |
| Gross profit | 25.458 | 14.051 | Gross margin approximately 45.2%, versus 32.2%. |
| Operating loss | (124.880) | (171.525) | Loss narrowed 27%; no impairment charge in 2023 versus $40.523 million in 2022. |
| Net loss | (55.660) | (228.295) | Loss narrowed substantially, primarily reflecting positive finance income and lower impairment. |
| Net finance income (expense) | 69.282 | (56.506) | Includes Stratasys investment revaluation gains and higher bank interest income. |
| Basic loss per share | $0.22 | $0.88 | Reported as a loss per share. |
| Operating cash flow | (105.069) | (92.054) | Cash used increased. |
| Investing cash flow | (166.600) | (67.673) | Primarily bank deposits and fixed assets. |
| Financing cash flow | (105.414) | (5.273) | Primarily share repurchases and lease payments. |
Revenue mix in 2023 was $43.929 million from systems, $7.795 million from consumables and $4.590 million from support services. Systems revenue remained the largest category. Adjusted EBITDA, a non-IFRS measure, was a loss of $99.942 million; EBITDA loss was $94.958 million.
Balance sheet and liquidity
- At December 31, 2023, cash and cash equivalents were $309.571 million and unrestricted short-term bank deposits were $541.967 million. The company also held $138.446 million of securities, principally its Stratasys investment, which is not equivalent to cash.
- Total current assets were $893.988 million against current liabilities of $34.472 million. Total assets were $1.064 billion and total liabilities were $48.552 million.
- Non-current bank loans were $0.595 million; lease liabilities totaled $13.215 million. The filing reports no material conventional debt burden, but these obligations and government-grant liabilities remain relevant.
- Management said available resources should fund business needs for at least the next 12 months, while noting capital needs could change with R&D, commercialization, legal costs and M&A.
- The company repurchased 32.016 million shares in 2023 for approximately $96.387 million. After year-end, it repurchased another 17.110 million shares for $46.150 million through March 15, 2024.
Material changes and unusual items
- Net finance income included a $23.462 million Stratasys share revaluation gain in the financial statement note and $45.904 million of bank interest income. The filing’s operating-results discussion attributes the year-over-year finance swing partly to the Stratasys revaluation and higher interest income; these non-operating items materially reduced the reported net loss.
- General and administrative expenses rose 91% to $58.254 million, mainly from proxy-contest, shareholder-related and litigation professional services. R&D and sales and marketing expenses fell 18% each, partly reflecting lower share-based compensation.
- A missile hit damaged inventory at a southern Israel warehouse. The company wrote off $4.959 million of inventory and recorded $3.774 million of net other income related to government compensation; it was pursuing additional insurance recovery for lost profit margin. The filing said the war had not materially affected operations or revenue to the reporting date, but described continuing uncertainty.
- The company’s $40.523 million 2022 impairment charge did not recur in 2023. Future impairments remain a risk, particularly given acquisition-related goodwill and intangible assets.
- The previously disclosed material weakness in Essemtec IT change-management controls was reported remediated; management and the auditor concluded internal control over financial reporting was effective as of December 31, 2023.
Outlook, risks and contingencies
No quantified revenue, earnings or margin guidance is provided. Management’s stated outlook is to continue investing in R&D and commercialization, develop consumables and industrial AI offerings, and pursue strategic acquisitions. It cautions that profitability depends on scaling sales and product commercialization; Nano Dimension has reported annual net losses since inception and an accumulated deficit of $591.207 million at year-end.
- Commercialization and execution: Customer adoption, sales cycles, product acceptance, competition, supply constraints and the ability to scale manufacturing and recurring consumables sales could affect growth and margins.
- Acquisition strategy: Integration, valuation, financing and impairment risks remain. The proposed Stratasys transaction was not accepted, and completion was uncertain; an acquisition could consume substantial cash and management attention.
- Israel and operations: The Israel-Hamas war, employee reservist call-ups, potential supply disruptions, facility damage and limited war-related insurance coverage could affect operations. Five employees were still on active duty as of March 15, 2024; the filing said the impact had been manageable then.
- Activist and other litigation: Multiple disputes involving Murchinson and related parties remained pending, as did a derivative-action certification motion concerning the DeepCube acquisition. Nano Dimension also reported litigation involving Stratasys. Outcomes and potential costs are uncertain.
- Government grants: IIA grants carry royalties, reported at 3%–3.5% of applicable product sales up to grant amounts plus interest, and restrictions on transferring funded technology or manufacturing outside Israel. The year-end recorded grant liability was $2.157 million; separate disclosure gives contingent liabilities of $1.986 million, so the difference should be reconciled against the detailed notes.
- Shareholder and tax considerations: A January 2024 rights plan can become exercisable at specified ownership thresholds and may dilute a triggering holder. The company said it may be a PFIC for U.S. tax purposes in 2023; investors should consult tax advisers. It does not expect to pay cash dividends in the foreseeable future.
Most important facts for investors to verify
- Whether revenue growth and improved gross margin are sustained, and whether recurring consumables and service revenue expand.
- How much of the 2023 net-loss improvement reflects recurring operating progress versus Stratasys revaluation, interest income and the absence of prior-year impairment.
- Cash burn, deposit maturities and yields, future repurchases, and remaining cash after any acquisition or investment commitments.
- Status and financial exposure of the Murchinson, DeepCube and Stratasys legal proceedings, including any effect on commercial discussions.
- Operational impact of the Israel conflict, insurance recovery for damaged inventory and any subsequent supply or workforce disruption.
- Whether the company’s rights plan, repurchases and any potential Stratasys transaction change share count, governance or capital allocation materially.